1-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-4-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazole

ID: ALA4476000

PubChem CID: 151428103

Max Phase: Preclinical

Molecular Formula: C20H16F3N5

Molecular Weight: 383.38

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc(Cn3cc(-c4cccc(C(F)(F)F)c4)nn3)cc2)cn1

Standard InChI:  InChI=1S/C20H16F3N5/c1-27-12-17(10-24-27)15-7-5-14(6-8-15)11-28-13-19(25-26-28)16-3-2-4-18(9-16)20(21,22)23/h2-10,12-13H,11H2,1H3

Standard InChI Key:  PBYFXEFTMBEMLE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   16.2171  -23.6386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9236  -24.0475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6293  -23.6369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6266  -22.8189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9124  -22.4131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2097  -22.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3323  -22.4067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0425  -22.8082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0462  -23.6288    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8279  -23.8790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3073  -23.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8219  -22.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1245  -23.2091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5325  -23.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3489  -23.9131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7551  -23.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3389  -22.4948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5238  -22.5017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5118  -24.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5109  -24.0499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7287  -23.7965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2461  -24.4622    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7301  -25.1268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4289  -24.4631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7417  -21.7839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5589  -21.7773    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.3274  -21.0795    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.1455  -21.0736    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 20  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 19  2  0
 22 24  1  0
 17 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476000

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TEK Tclin Tyrosine-protein kinase TIE-2 (3348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.38Molecular Weight (Monoisotopic): 383.1358AlogP: 4.41#Rotatable Bonds: 4
Polar Surface Area: 48.53Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.83CX LogP: 4.73CX LogD: 4.73
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -2.15

References

1. Shan Y, Si R, Wang J, Zhang Q, Zhou H, Song J, Zhang J, Chen Q..  (2019)  Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs.,  164  [PMID:30616052] [10.1016/j.ejmech.2018.12.067]

Source